Evidence map›Paper›PMID 41721588›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Simultaneous Imaging of Cu

Xiangli Shao, Zhenglin Yang, Zhihao Xu, Weijie Guo, Whitney Lewis, Boyi Gan, Yi Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiangli ShaoDepartment of Chemistry, University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0001-8118-6414
Zhenglin YangDepartment of Chemistry, University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-2743-5779
Zhihao XuDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Weijie GuoDepartment of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0001-5694-2142
Whitney LewisDepartment of Chemistry, University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-1203-6441
Boyi GanDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yi LuDepartment of Chemistry, University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-1221-6709

Funding

Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibitionU54CA274220 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Steven Hsesheng Lin · 2022 to 2026
$8.4M
Design and Selection of Novel Metalloenzymes for Biocatalysis, Bioimaging, and Genetic EngineeringR35GM141931 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Yi Lu · 2021 to 2026
$3.5M
Targeting ferroptosis in cancer therapyR01CA269646 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Boyi Gan · 2023 to 2026
$2.0M
Cancer Prevention and Research Institute of Texas (CPRIT) RP240061NCI NIH HHS R01 CA269646NCI NIH HHS U54 CA274220NIGMS NIH HHS R35 GM141931The Robert A. Welch Foundation F-0020The University of Texas at Austin and The University of Texas MD Anderson Cancer Center: the Collaborative Accelerator for Transformative Research Endeavors grantUS National Institute of Health GM141931
6 · The paper itself

Abstract

Copper dysregulation is implicated in neurodegenerative diseases such as Alzheimer's disease (AD), yet its precise role in neuronal death remains unclear. To address this issue, here, we introduce a pair of Cu

Indexed as

Amyloid beta-PeptidesCopperFluorescent DyesNeuronsAnimalsCuproptosisFluorescent Chemosensor CompoundsHumansOxidation-ReductionReactive Oxygen SpeciesAmyloid beta-PeptidesCopperFluorescent Chemosensor CompoundsFluorescent DyesReactive Oxygen SpeciesAβ‐treated neuron cellscopper homeostasiscuproptosisDNAzyme probesROS generation

Identifiers

PMID41721588
PMCPMC13023722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.